Caplin One Labs

Caplin One Labs is a specialized research and development subsidiary of Caplin Point Laboratories, located in Chennai, India. The facility is dedicated to the development of complex generic pharmaceutical products, with a core focus on injectable and ophthalmic formulations. It serves as a strategic innovation hub designed to support the parent company's expansion into highly regulated markets, such as the United States and the European Union. The laboratory handles advanced formulation development, analytical research, and the preparation of Abbreviated New Drug Application (ANDA) filings. By targeting high-entry-barrier niche segments, Caplin One Labs plays a critical role in the group's transition toward technically demanding therapeutic categories. The center operates under international quality standards to ensure compliance with global regulatory requirements.